In 2010, Dr. Rossi discovered a groundbreaking method to reprogram skin cells into stem cells utilizing messenger molecules. His novel technique eliminated the risk of cancer posed by previous methods and sparked a push to develop cellular and molecular therapeutic products using the technologies he developed. More recently, Dr. Rossi and colleagues again innovated in the stem cell field by applying the CRISPR/Cas9 system to generate hematopoietic stem cells resistant to HIV infection. Dr. Rossi continues to study CRISPR for application in human therapeutics.
Organization Name | Title At Company | Start Date | End Date | |
---|---|---|---|---|
Moderna Therapeutics | Co-Founder | Jan 1, 2010 | — | Detail |
Intellia Therapeutics | Founder | — | — | Detail |